Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Clinicians should retain clinical classification for cardiomyopathies; leaves open whether future genetic advances will guide therapy.
Jacoby et al. (2011) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: